Literature DB >> 23188219

Safety of major abdominal surgical procedures in patients with hyperimmunoglobulinemia E (Job's syndrome): a changing paradigm?

Russell C Langan1, Richard M Sherry, Itzhak Avital, Theo Heller, Carolyn Henderson, Steven M Holland, Alexandra F Freeman, Udo Rudloff.   

Abstract

INTRODUCTION: Autosomal dominant hyperimmunoglobulinemia E syndrome (HIES), also called Job's syndrome, is a primary immunodeficiency characterized by the triad of elevated immunoglobulin E levels, eczema, and infections. Its clinical course manifests as recurrent skin and pulmonary infections, and variable skeletal, connective tissue, and vascular abnormalities. There is evidence of abnormal tissue remodeling with pneumatocoeles frequently complicating pyogenic pneumonias and leading to secondary infections that cause the majority of morbidity and mortality. Complications are known to occur after lung surgery with a high frequency of bronchopleural fistulae, but little has been reported concerning abdominal surgeries. DISCUSSION: Here, we report on the outcome and safety of two separate complex cases (hepatectomy and subtotal gastrectomy) and document our entire experience with abdominal surgical procedures performed on patients with HIES. Despite initial complications, all patients eventually made a full recovery.
CONCLUSION: As HIES patients now frequently live beyond the third and fourth decade, surgical issues similar to those in the general population may increase. Complex surgical procedures can be performed safely and benefit select patients with HIES, but benefit strongly from multidisciplinary teams and awareness of complications related to abnormal healing. We discuss current treatment and potential complications post-operatively in patients with HIES.

Entities:  

Mesh:

Year:  2012        PMID: 23188219      PMCID: PMC7596843          DOI: 10.1007/s11605-012-2077-1

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  15 in total

Review 1.  Hyper-IgE syndrome update.

Authors:  Kathryn J Sowerwine; Steven M Holland; Alexandra F Freeman
Journal:  Ann N Y Acad Sci       Date:  2012-01-23       Impact factor: 5.691

2.  Successful long-term immunologic reconstitution by allogeneic hematopoietic stem cell transplantation cures patients with autosomal dominant hyper-IgE syndrome.

Authors:  Evgenios Goussetis; Ioulia Peristeri; Vasiliki Kitra; Joanne Traeger-Synodinos; Maria Theodosaki; Katerina Psarra; Maria Kanariou; Fotini Tzortzatou-Stathopoulou; Eftichia Petrakou; Irene Fylaktou; Emmanuel Kanavakis; Stelios Graphakos
Journal:  J Allergy Clin Immunol       Date:  2010-07-02       Impact factor: 10.793

3.  Diverticulitis in a young man with hyper-IgE syndrome.

Authors:  Daniel G Stover; Alexandra F Freeman; Patty W Wright; Donna S Hummell; Reid M Ness
Journal:  South Med J       Date:  2010-12       Impact factor: 0.954

4.  Paucity of genotype-phenotype correlations in STAT3 mutation positive Hyper IgE Syndrome (HIES).

Authors:  Jennifer Heimall; Joie Davis; Pamela A Shaw; Amy P Hsu; Wenjuan Gu; Pam Welch; Steven M Holland; Alexandra F Freeman
Journal:  Clin Immunol       Date:  2011-01-14       Impact factor: 3.969

5.  Job's Syndrome. Recurrent, "cold", staphylococcal abscesses.

Authors:  S D Davis; J Schaller; R J Wedgwood
Journal:  Lancet       Date:  1966-05-07       Impact factor: 79.321

6.  Causes of death in hyper-IgE syndrome.

Authors:  Alexandra F Freeman; David E Kleiner; Hari Nadiminti; Joie Davis; Martha Quezado; Victoria Anderson; Jennifer M Puck; Steven M Holland
Journal:  J Allergy Clin Immunol       Date:  2007-03-01       Impact factor: 10.793

7.  Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by interferon gamma.

Authors:  C L King; J I Gallin; H L Malech; S L Abramson; T B Nutman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

8.  Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome.

Authors:  Joshua D Milner; Jason M Brenchley; Arian Laurence; Alexandra F Freeman; Brenna J Hill; Kevin M Elias; Yuka Kanno; Christine Spalding; Houda Z Elloumi; Michelle L Paulson; Joie Davis; Amy Hsu; Ava I Asher; John O'Shea; Steven M Holland; William E Paul; Daniel C Douek
Journal:  Nature       Date:  2008-03-12       Impact factor: 49.962

9.  Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.

Authors:  Cristina Woellner; E Michael Gertz; Alejandro A Schäffer; Macarena Lagos; Mario Perro; Erik-Oliver Glocker; Maria C Pietrogrande; Fausto Cossu; José L Franco; Nuria Matamoros; Barbara Pietrucha; Edyta Heropolitańska-Pliszka; Mehdi Yeganeh; Mostafa Moin; Teresa Español; Stephan Ehl; Andrew R Gennery; Mario Abinun; Anna Breborowicz; Tim Niehues; Sara Sebnem Kilic; Anne Junker; Stuart E Turvey; Alessandro Plebani; Berta Sánchez; Ben-Zion Garty; Claudio Pignata; Caterina Cancrini; Jiri Litzman; Ozden Sanal; Ulrich Baumann; Rosa Bacchetta; Amy P Hsu; Joie N Davis; Lennart Hammarström; E Graham Davies; Efrem Eren; Peter D Arkwright; Jukka S Moilanen; Dorothee Viemann; Sujoy Khan; László Maródi; Andrew J Cant; Alexandra F Freeman; Jennifer M Puck; Steven M Holland; Bodo Grimbacher
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

Review 10.  Clinical manifestations of hyper IgE syndromes.

Authors:  Alexandra F Freeman; Steven M Holland
Journal:  Dis Markers       Date:  2010       Impact factor: 3.434

View more
  1 in total

Review 1.  Hyper-IgE Syndromes and the Lung.

Authors:  Alexandra F Freeman; Kenneth N Olivier
Journal:  Clin Chest Med       Date:  2016-06-10       Impact factor: 2.878

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.